Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Glenmark Pharmaceuticals Ltd (GLENMARK-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 Feb 2016 Thomson Reuters Stock Report 11 $25.00

MOSL: Glenmark Pharma 3QFY16 (neutral)-Results below estimates-LatAm and US underperform

GLENMARK PHARMA 3QFY16: Results below estimates; LatAm and US underperform (GNP IN, Mkt Cap USD3.1b, CMP INR771, TP INR900, ...

01 Feb 2016 Motilal Oswal Securities Ltd. 12 $115.00

Glenmark Pharma (GNP) - Qtr. Update - Dated - January 29, 2016

Glenmark Pharma (Bloomberg: GNP IN; HOLD; TP – Rs 800; 4% upside from CMP of Rs 771) Glenmark's (GNP) revenue grew 5% YoY...

29 Jan 2016 Axis Capital Limited 8 $81.00

Glenmark Pharmaceuticals | Q3FY16 Result Update | Muted performance for the quarter; Maintain BUY on valuation

Glenmark Pharmaceuticals Muted performance for the quarter; Maintain BUY on valuation Glenmark Pharmaceuticals (GNP IN) s...

29 Jan 2016 IndiaNivesh Securities Pvt Ltd 5 $46.00

Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

26 Jan 2016 Wright Reports 55 $75.00

Will Glenmark Pharmaceuticals Ltd Deliver Long-Term Returns?

08 Jan 2016 Sadif Analytics Prime 12 $25.00

Company Snapshot - Glenmark Pharmaceuticals Limited

A director at Glenmark Pharmaceuticals Limited bought 8,230 shares at 885.561INR and the significance rating of the trade was...

15 Dec 2015 Directors Deals Ltd. 1 $12.00

MOSL: Glenmark Pharma (Neutral) - Results ahead of estimates - India, US and SRM outperform

Glenmark Pharma 2QFY16: Results ahead of estimates; India, US and SRM outperform (GNP IN, Mkt Cap USD4.1b, CMP INR992, TP IN...

02 Nov 2015 Motilal Oswal Securities Ltd. 14 $138.00

Glenmark Pharma (GNP) - Qtr. Update - Dated - October 30, 2015

Glenmark Pharma (Bloomberg: GNP IN; HOLD; TP – Rs 950; 1% upside from CMP of Rs 944) Glenmark's (GNP) revenue grew 14% YoY...

30 Oct 2015 Axis Capital Limited 8 $81.00